Below are the top drugs wholesale stocks on the NYSE and the NASDAQ in terms of revenue estimate for the current year.
McKesson MCK is likely to post revenue of $123.73 billion in the year ending March, 2013. McKesson's PEG ratio is 1.15.
Analysts expect Cardinal Health CAH to post revenue of $100.60 billion for the year ending June, 2013. Cardinal Health's trailing-twelve-month ROE is 18.35%.
AmerisourceBergen ABC is expected to report revenue of $86.33 billion for the year ending September, 2013. AmerisourceBergen had $417.40 million in total cash for the latest quarter.
Omnicare OCR may report revenue of $6.15 billion in the year ending December, 2013. Omnicare's trailing-twelve-month operating margin is 9.16%.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: Trading IdeasDrugs Wholesale IndustryHealth CareHealth Care DistributorsHighest Revenue Estimates
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in